NASDAQ · NAMS
NewAmsterdam Pharma Company N.V.
Healthcare · Biotechnology
$20.06
Down-$0.70 (-3.37%)
Updated Nov 2, 2026, 11:44 AM
SID Score
3.8/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 4.1B
- P/E ratio
- -19.49
- Dividend yield
- 0.00%
- 52-week range
- $19.13 – $42.21
- Volume
- 1.14M
- Avg. volume
- 1.15M
Price performance · NAMS
NAMS price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
NAMS closed at $20.06 after 20 trading sessions, down 12.02% for the selected period.
- Last close
- $20.06
- Period change
- -12.02%
- Period low
- $19.53
- Period high
- $22.80
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $20.60 | $20.94 | $19.78 | $20.06 | 1.14M |
| Oct 29, 2026 | $21.45 | $21.725 | $20.55 | $20.76 | 1.03M |
| Oct 28, 2026 | $20.59 | $21.115 | $20.09 | $21.07 | 1.45M |
| Oct 27, 2026 | $19.50 | $20.60 | $19.32 | $20.50 | 1.97M |
| Oct 26, 2026 | $19.68 | $19.98 | $19.265 | $19.53 | 1.56M |
| Oct 23, 2026 | $21.39 | $21.39 | $19.13 | $19.71 | 2.31M |
| Oct 22, 2026 | $21.25 | $22.251 | $21.25 | $21.58 | 1.7M |
| Oct 21, 2026 | $21.58 | $22.29 | $21.31 | $21.49 | 1.25M |
| Oct 20, 2026 | $20.57 | $21.94 | $20.36 | $21.50 | 1.08M |
| Oct 19, 2026 | $19.99 | $20.60 | $19.845 | $20.47 | 724.79K |
| Oct 16, 2026 | $20.51 | $20.665 | $19.71 | $19.83 | 1.94M |
| Oct 15, 2026 | $20.30 | $21.12 | $20.21 | $20.62 | 881.96K |
| Oct 14, 2026 | $20.08 | $20.75 | $19.58 | $20.01 | 2.19M |
| Oct 13, 2026 | $21.20 | $21.335 | $20.04 | $20.19 | 989.72K |
| Oct 12, 2026 | $21.28 | $21.97 | $21.04 | $21.25 | 812.29K |
| Oct 9, 2026 | $21.25 | $21.79 | $21.02 | $21.575 | 1.27M |
| Oct 8, 2026 | $22.00 | $22.13 | $20.91 | $21.26 | 1.67M |
| Oct 7, 2026 | $22.07 | $22.72 | $21.85 | $22.13 | 1.38M |
| Oct 6, 2026 | $23.06 | $23.11 | $21.4442 | $22.27 | 1.27M |
| Oct 5, 2026 | $22.84 | $23.34 | $22.23 | $22.80 | 1.18M |
Latest NAMS news
The latest Smart Investors Daily articles mentioning NAMS.
Stock researchMarket Activity · Sentiment
Company
Market Activity
Research & News

